Patients with acute leukemia prioritize tiredness as the most important health dimension over cognition, differing from the general public's preferences. Informal caregivers report significant ...
An anthracycline-free treatment regimen demonstrated safety and efficacy in standard-risk and high-risk patients.
In the past 25 years — from 2000 to 2024 — we have witnessed a revolution in the management, treatment, and outcome of what used to be the most lethal hematologic cancer: Philadelphia ...
Precursor B-cell acute lymphoblastic leukemia is a fast-growing leukemia that affects early B cells in bone marrow. It’s both more common and has a better outlook in children. Leukemia is a type of ...
For years, treatment of older patients with acute myeloid leukemia—an aggressive cancer of the blood and bone marrow—has ...
5don MSN
Inhibiting high levels of leukemia ABCD1 protein with jojoba could lead to new treatment option
University of Guelph research published in the journal publication Blood has uncovered a surprising weakness in acute myeloid ...
The CytoCell KMT2A Breakapart FISH Probe Kit PDx is approved as a companion diagnostic for revumenib in KMT2A translocated acute leukemia. Revumenib showed a 21.2% complete remission rate in ...
Acute leukemia is a group of hematologic malignancies categorized according to the immature cells that proliferate and replace the normal bone marrow. Flow cytometry has emerged as a cornerstone in ...
Secondary acute myeloid leukemia (AML) is a blood cancer that arises from other blood disorders or previous cancer treatment. Those with secondary AML tend to have a less favorable outlook than those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results